GLP-1 Daily: Ozempic & Wegovy News
GLP-1 Users Lost Sight in the Second Eye Sooner, Ophthalmology Study Finds as Vision-Loss Lawsuits Grow
Thursday, October 8, 2026 · 11 min
An American Academy of Ophthalmology meeting study links GLP-1 use to faster second-eye NAION, as federal eye-injury cases climb to 247; plus Medicare Bridge paperwork gaps for cash-pay patients, pharmacists seeing more cash GLP-1 fills, the WHO's first childhood obesity guidelines, and Korea's first homegrown GLP-1 obesity drug.
Listen
Show notes
An American Academy of Ophthalmology meeting study links GLP-1 use to faster second-eye NAION, as federal eye-injury cases climb to 247; plus Medicare Bridge paperwork gaps for cash-pay patients, pharmacists seeing more cash GLP-1 fills, the WHO's first childhood obesity guidelines, and Korea's first homegrown GLP-1 obesity drug.
In this episode
- GLP-1 Drugs Linked to Faster Vision Loss in the Second Eye, New Study Finds | Newswise — American Academy of Ophthalmology (AAO
GLP-1 Drugs Linked to Faster Vision Loss in the Second Eye, New Study Finds | Newswise # GLP-1 Drugs Linked to Faster Vision Loss in the Second Eye, New Study Finds ###### Among patients who suffered a rare optic nerve stroke in both eyes, those taking GLP-1 drugs saw the second eye affected sooner. They caution that causation hasn’t been established, only an association. 6-Oct-2026 at 9:30…
- Medicare’s Missing On-Ramp For Access To GLP-1s For Weight Management | Health Affairs — T. Joseph Mattingly II
Medicare’s Missing On-Ramp For Access To GLP-1s For Weight Management | Health Affairs # Medicare’s Missing On-Ramp For Access To GLP-1s For Weight Management - T. Joseph Mattingly II, - Rena M. Conti, - and - Sean D. Sullivan October 7, 2026 Medicare’s GLP-1 Bridge program is off to a fast start, but gaps in prior authorization design may exclude beneficiaries who began GLP-1 therapy…
- Patients increasingly bypass insurance to pay cash for GLP-1 prescriptions, pharmacists say — Bill Schiffner
Patients increasingly bypass insurance to pay cash for GLP-1 prescriptions, pharmacists say # Patients increasingly bypass insurance to pay cash for GLP-1 prescriptions, pharmacists say The trend reflects the rapidly evolving GLP-1 marketplace. , and Bill Schiffner October 7, 2026 . 10:06 AM HIALEAH, Fla. — A growing number of patients are choosing to pay cash for GLP-1 medications…
- Should kids living with obesity be on GLP-1s? New global guidance says yes — in some cases — CBC News
Should kids living with obesity be on GLP-1s? New global guidance says yes — in some cases ## Should kids living with obesity be on GLP-1s? New global guidance says yes — in some cases New Lauren Pelley | CBC News | Posted: October 7, 2026 8:00 AM | Last Updated: Just now World Health Organization has released its first-ever guidelines on managing childhood obesity Image | VANCOUVER NEW…
- MFDS approves Hanmi's EPPE, Korea's first homegrown GLP-1 obesity drug · Local Chorus — Local Chorus
MFDS approves Hanmi's EPPE, Korea's first homegrown GLP-1 obesity drug · Local Chorus # MFDS approves Hanmi's EPPE, Korea's first homegrown GLP-1 obesity drug 🇰🇷 South Korea, Seoul 09:37 Health Business 8 Official updated 2 h ago first reported by 서울경제 Copy link ## In short Korea's Ministry of Food and Drug Safety approved Hanmi Pharmaceutical's EPPE auto-injector (efpeglenatide) on Oct 7,…